Gene: FAP
Official Full Name: fibroblast activation protein alphaprovided by HGNC
Gene Summary: The protein encoded by this gene is a homodimeric integral membrane gelatinase belonging to the serine protease family. It is selectively expressed in reactive stromal fibroblasts of epithelial cancers, granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas. This protein is thought to be involved in the control of fibroblast growth or epithelial-mesenchymal interactions during development, tissue repair, and epithelial carcinogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00699 | FAP gRNA3-gRNA4 KO plasmid | FAP | $850 | |||
GP00700 | FAP gRNA1-gRNA2 KO plasmid | FAP | $850 | |||
KO00703 | FAP Knockout cell line(U-87 MG) | Human | FAP | 1:3~1:4 | Negative | Online Inquiry |
KO09995 | FAP Knockout cell line (HeLa) | Human | FAP | 1:3~1:6 | Negative | Online Inquiry |
FAP Gene Knockout Cell Lines are genetically engineered cellular models that have been created to specifically disrupt the fibroblast activation protein (FAP) gene, a crucial element in various biological processes such as tumor progression and tissue remodeling. These cell lines serve as an invaluable tool for researchers investigating the role of FAP in cancer biology, fibrosis, and immune response modulation. By silencing the FAP gene, researchers can elucidate its functional contributions to cell behavior and signaling pathways, thus enabling a deeper understanding of pathophysiological mechanisms and potential therapeutic targets.
The primary mechanism of FAP Gene Knockout Cell Lines involves the targeted editing of the FAP gene using advanced techniques such as CRISPR-Cas9 or RNA interference. This precise gene disruption leads to a notable change in cellular phenotype and function, allowing researchers to conduct comparative studies with wild-type cells. As FAP is upregulated in various cancers and fibrotic conditions, these knockout cell lines hold significant promise as a model for studying tumor microenvironments, scaffold remodeling, and interstitial remodeling processes.
In scientific and clinical research settings, FAP Gene Knockout Cell Lines are crucial for the validation of drug targets and the development of novel therapeutic strategies. Their use can facilitate the discovery of FAP inhibitors or modulators, which may have significant implications in cancer therapy and fibrosis treatment. Compared to traditional cell lines, these knockout models provide a higher level of specificity and control, enabling more reliable and reproducible experimental results.
Researchers and clinicians can greatly benefit from the innovative potential of FAP Gene Knockout Cell Lines. By utilizing these advanced tools, they can accelerate the pace of discovery, enhance therapeutic development, and ultimately improve patient outcomes. Our company prides itself on its commitment to providing high-quality, genetically modified cell lines and has leveraged years of expertise in molecular biology to deliver reliable, cutting-edge products that empower scientists in their quest for knowledge and breakthroughs in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.